OCALA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech, Inc. (NYSEAM:AIM) (“AIM ImmunoTech” or the “Company”), a late-stage biotechnology company focused on the discovery and development of ...
AIM ImmunoTech ( (AIM)) just unveiled an update. On May 8, 2026, AIM ImmunoTech closed a warrant exercise inducement transaction in which existing warrant holders agreed to exercise warrants for 7,451 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results